{"id":"W4286255965","doi":"10.1016/j.jaad.2022.07.019","title":"Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial","year":2022,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"LEO Pharma Research Foundation","keywords":"Medicine; Adverse effect; Atopic dermatitis; Eczema Area and Severity Index; Placebo; Incidence (geometry); Interim analysis; Pediatrics; Clinical endpoint; Confidence interval; Randomized controlled trial; Post-hoc analysis; Physical therapy; Internal medicine; Dermatology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01011118,0.001227089,0.001944714,0.0003288322,0.0005575282,0.001541456,0.00067758,0.001253972,0.003758576],"category_scores_gemma":[0.006034574,0.0004500763,0.003650832,0.0003557658,0.0005621087,0.001455312,0.0007222728,0.002520931,0.0007656392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004960102,"about_ca_system_score_gemma":0.001018997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003698415,"about_ca_topic_score_gemma":0.0007276228,"domain_scores_codex":[0.9974518,0.001176359,0.000207554,0.0004126216,0.0003446563,0.0004068157],"domain_scores_gemma":[0.9956678,0.00109311,0.001465331,0.0007746846,0.0004239785,0.0005750714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9096885,0.005663028,0.04068539,0.0007049025,0.006084736,0.0001659174,0.0001503635,0.001304833,0.002813934,0.0002299797,0.00333691,0.02917156],"study_design_scores_gemma":[0.4486814,0.2575592,0.2570403,0.0003194313,0.01793262,0.0007737019,0.000200053,0.003730237,0.0050283,0.001190571,0.007415782,0.0001283605],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873571,0.003228519,0.001144203,0.0003205156,0.0001697002,0.001338394,0.004376238,0.00007658835,0.001988715],"genre_scores_gemma":[0.9870979,0.0006155263,0.001117382,0.000455085,0.0001954741,0.001883541,0.007112467,0.00002088547,0.001501684],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01011118,"threshold_uncertainty_score":0.05347371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02098853639196383,"score_gpt":0.3210321999785117,"score_spread":0.3000436635865478,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}